Mark Roshelli, MBA, FACHE

Mark Roshelli, MBA, FACHE

Followers of Mark Roshelli, MBA, FACHE2000 followers
location of Mark Roshelli, MBA, FACHEApex, North Carolina, United States

Connect with Mark Roshelli, MBA, FACHE to Send Message

Connect

Connect with Mark Roshelli, MBA, FACHE to Send Message

Connect
  • Timeline

  • About me

    Director Of Business Development at Select Medical

  • Education

    • ECU

      -
      Bachelor of Science Business Administration
    • Thomas Jefferson University

      2015 -
      Population Health Academy

      Activities and Societies: Health Care Quality & Safety, Health Economics & Population Health, Prevention & Chronic Disease Management, Data Analytics Case Based Exploration of the Critical Challenges and Opportunities in the US Healthcare System

    • East Carolina University

      -
      MBA
  • Experience

    • Sanofi

      Jan 2009 - Dec 2017

      Account Executive responsible for the portfolio access and pull through of Payer and Integrated Delivery Networks (IDNs) in the NC and SC markets for oncology, diabetes, cardiovascular, renal, and osteoarthritis brands. Lead executive level collaborations across Payers, IDNs, ACOs, and PCMHs. Execute contracts with aligned hospital accounts. Develop and implement integrated health care solutions through better population health management, quality, and transitions of care. Develop / implement cross-functional strategies involving brand team, contracting, national account executives, medical liaisons, and regional directors generating over $90 million aggregate portfolio sales. Key Accounts: BCBS NC, BCBS SC, Cigna, Aetna, Humana, NC State Health Plan, Novant, Duke Health System, UNC Healthcare, Cone Health, Vidant, Wake Forest Baptist, Cape Fear Valley, Wilmington Health, Physicians East, and Cornerstone.Key Acheivements:Winner of the Sanofi 2015 World Champions for Customers Award” which recognizes the Top 1% Internationally in sales achievementWinner of Q3 2016 Excellence in Leadership AwardWinner of 2016 Distinguished Account Achievement AwardLaunched Toujeo, Afrezza, Praluent, and Soliqua:- #1 in the Mid-Atlantic Region and Top 15% Nationally in Toujeo market share, - #2 Nationally for Toujeo market share among Prime Therapeutics affiliates,- #1 in the Region and #2 Nationally in Afrezza Volume- Achieved preferred access for Toujeo and Praluent at top regional payer accounts- Improved UM Criteria for Praluent leading to 80% increase in sales volume- Initiated/developed Specialty Pharmacy access sites for Praluent with 4 key institutions- Garnered positive formulary access for Praluent for key Specialty Pharmacy- Successfully defended intrusion of follow-on biologic that resulted in exclusive access for Lantus and Toujeo for 2017 Show less

      • Account Executive, US Market Access

        Dec 2012 - Dec 2017
      • Senior Executive Sales Professional

        Jan 2011 - Dec 2012
      • Long Term Care Specialty Representative

        Jan 2009 - Dec 2010
    • Critical Access Network

      Jan 2018 - Jul 2018
      Senior Director, Business Development

      Healthcare consulting on go to market strategiesWorkforce solutions, executive searches, telehealth

    • Select Medical

      Aug 2018 - now
      Director Of Business Development
  • Licenses & Certifications